logo
[breadcrumb_custom]

Tag: MTNB Stock

SLGG
News

Company’s Banking Stock: Dissecting a 34.10% Quarterly Revenue Decline Amid Growth

Matinas Biopharma Holdings Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $0.89 on 10/11/23, with the lowest value being $0.11 on 08/10/23. 52-week price history of MTNB Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Matinas Biopharma Holdings Inc’s current trading price is -67.39% away from its 52-week high, while its distance from the 52-week low is 163.10%. The stock’s price range for this period has remained between $0.11 and $0.89.

ZM Stock
Finance

Matinas Biopharma Holdings Inc (MTNB) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Matinas Biopharma Holdings Inc’s current trading price is -68.10% away from its 52-week high, while its distance from the 52-week low is 157.39%. The stock’s price range over this period has fluctuated between $0.11 and $0.89. The company, operating within the financial sector, had a trading volume of approximately 18.61 million for the day, which was noticeably higher than the average daily share volume of 0.99 million over the last 3 months. In terms of market performance,

Stock

Matinas Biopharma Holdings Inc (MTNB) Stock: A Year of Stock Market Ups and Downs

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Matinas Biopharma Holdings Inc’s current trading price is -66.29% away from its 52-week high, while its distance from the 52-week low is 171.99%. The stock’s price range over this period has fluctuated between $0.11 and $0.89. The company, operating within the financial sector, had a trading volume of approximately 3.83 million for the day, which was noticeably higher than the average daily share volume of 0.98 million over the last 3 months. The market performance of Matinas

THMO
News

Matinas Biopharma Holdings Inc (MTNB) Stock: From Low to High in 52 Weeks

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Matinas Biopharma Holdings Inc’s current trading price is -73.54% away from its 52-week high, while its distance from the 52-week low is 113.51%. The stock’s price range for this time frame has been between $0.11 and $0.89. The trading volume of the company’s shares in the Healthcare reached around 0.94 million for the day, which was evidently lower than the average daily volume of 0.97 million over the last three months. In terms of market performance, Matinas Biopharma Holdings

Stock

MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect?

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 10.73% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 26.67%. Over the past 30 days, the price of MTNB has fallen by 21.52%. And in the last five days, it has surged by 9.02%. Matinas Biopharma Holdings Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was

ZM Stock
Finance

Matinas Biopharma Holdings Inc (MTNB) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Matinas Biopharma Holdings Inc’s current trading price is -71.28% away from its 52-week high, while its distance from the 52-week low is 131.73%. The stock’s price range over this period has fluctuated between $0.11 and $0.89. The company, operating within the financial sector, had a trading volume of approximately 3.78 million for the day, which was noticeably higher than the average daily share volume of 0.96 million over the last 3 months. In terms of market performance,

ZM Stock
Finance

Anchoring Your Portfolio: Is MTNB Stock a Safe Harbor?

Matinas Biopharma Holdings Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $0.89 on 10/11/23 and the lowest value was $0.11 on 08/10/23. 52-week price history of MTNB Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Matinas Biopharma Holdings Inc’s current trading price is -78.69% away from its 52-week high, while its distance from the 52-week low is 71.99%. The stock’s price range during this period has spanned from $0.11 to $0.89. In the Healthcare sector, the Matinas Biopharma Holdings Inc’s